Antibodies to vascular endothelial growth factor 2 (VEGF-2)
US7402312B2 · kind B2 · utility
106Cited by
20References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2004 |
| Grant date | Jul 22, 2008 |
| Priority date | — |
| Expiry date | Jul 12, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention also relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.